|
Feng, Y; Burgess, K; Pledger, D et al. (1998) A labeled guanidine ligand for studying sweet taste. Bioorg Med Chem Lett 8:881-4
|
|
Burgess, K; Li, W; Linthicum, D S et al. (1997) Libraries of opiate and anti-opiate peptidomimetics containing 2,3-methanoleucine. Bioorg Med Chem 5:1867-71
|
|
Malin, D H; Lake, J R; McDermitt, L S et al. (1996) Enhanced antiopiate activity and enzyme resistance in a peptidomimetic of FMRFamide containing E-2,3-methanomethionine and E-2,3-methanophenylalanine. Peptides 17:83-6
|
|
Malin, D H; Lake, J R; Short, P E et al. (1996) Nicotine abstinence syndrome precipitated by an analog of neuropeptide FF. Pharmacol Biochem Behav 54:581-5
|
|
Malin, D H; Lake, J R; Jones, J A et al. (1996) Nitric oxide synthesis inhibition attenuates behavioral actions of neuropeptide FF. Peptides 17:615-8
|
|
Malin, D H; Lake, J R; Smith, D A et al. (1995) Subcutaneous injection of an analog of neuropeptide FF prevents naloxone-precipitated morphine abstinence syndrome. Drug Alcohol Depend 40:37-42
|
|
Malin, D H; Lake, J R; Payza, K et al. (1993) Enhanced antiopiate activity and enzyme resistance in peptidomimetics of FMRFamide containing (E)-2,3-methanomethionine. Peptides 14:731-4
|
|
Malin, D H; Payza, K; Lake, J R et al. (1993) Enhanced antiopiate activity in peptidomimetics of FMRFamide containing Z-2,3-methanomethionine. Peptides 14:47-51
|
|
Malin, D H; Lake, J R; Arcangeli, K R et al. (1993) Subcutaneous injection of an analog of neuropeptide FF precipitates morphine abstinence syndrome. Life Sci 53:PL261-6
|
|
Lake, J R; Hebert, K M; Payza, K et al. (1992) Analog of neuropeptide FF attenuates morphine tolerance. Neurosci Lett 146:203-6
|
